Etanautine

Etanautine is a antipsychotic drug of the phenothiazine class which was introduced in Europe in the 1950s for the treatment of schizophrenia and psychosis. It is not commonly used today.

Pharmacology

Etanautine is a phenothiazine derivative. It is classified as an antipsychotic, and has been used in the treatment of schizophrenia and other forms of psychosis. The exact mechanism of action of etanautine is not known, but it is believed to work by blocking dopamine receptors in the brain, which helps to reduce symptoms such as hallucinations and delusions.

Side effects

Like other phenothiazine derivatives, etanautine can cause a range of side effects. These can include drowsiness, dizziness, dry mouth, blurred vision, constipation, and weight gain. In rare cases, it can also cause more serious side effects such as tardive dyskinesia (a movement disorder), neuroleptic malignant syndrome (a potentially life-threatening reaction to antipsychotic drugs), and agranulocytosis (a serious blood disorder).

History

Etanautine was first introduced in Europe in the 1950s for the treatment of schizophrenia and psychosis. However, it is not commonly used today, with newer antipsychotic drugs generally being preferred due to their improved safety and efficacy profiles.

See also

• Phenothiazine
• Antipsychotic
• Schizophrenia
• Psychosis

Etanautine Resources
Latest articles Most recent articles Ongoing trials	Wikipedia